AK

Abdul Khader Vattapparambil

Active Director Designated Partner DIN 11332316
DIN 11332316 First appointment Oct 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Abdul Khader Vattapparambil

Data last updated:

Abdul Khader Vattapparambil is a Designated Partner at Zortex Pharmaceuticals Llp (since 2025) and Designated Partner at Zyfam Pharmaceuticals Llp (since 2025). The companies operate in Pharma.

DIN 11332316
Primary Designation Designated Partner
Industry Pharma
First Appointment 08 Oct 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner13 Nov 20252025Active
Designated Partner08 Oct 20252025Active

Directorship timeline

Open interactive timeline →
Zortex Pharmaceuticals Llp
Zyfam Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Abdul Khader Vattapparambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abdul Khader Vattapparambil

Abdul Khader Vattapparambil currently holds 2 directorships: Zortex Pharmaceuticals Llp (Designated Partner, since 13 Nov 2025); Zyfam Pharmaceuticals Llp (Designated Partner, since 08 Oct 2025).

Abdul Khader Vattapparambil was first appointed on 08 Oct 2025 as Designated Partner at Zyfam Pharmaceuticals Llp.

The current boards of Abdul Khader Vattapparambil's companies include Kuttasseri Fathimath Zuhra (Zortex Pharmaceuticals Llp), Palamadathil Kozhissery Mohammed Shafi (Zortex Pharmaceuticals Llp), Ramakrishnan Kizhakke Kalarikkal (Zortex Pharmaceuticals Llp), Shabeerali (Zortex Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available